Filtyp
Published 26 August 2024 Anna France and David Gardner from Leeds University Business School. Photo: Maria Johansson “External engagement is at the centre of what happens at Leeds University Business School (LUBS), be it with partner companies, NGOs or alumni. It’s a bridge between these levels and the students, researchers and teachers at our school and a high priority of our’s”, says Anna France
https://www.lusem.lu.se/internal/article/leeds-comes-lund - 2025-02-11
By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 21 October 2024 A wide variety of digital tools can be used to monitor symptoms of neurodegenerative diseases. Pictures generated with Gencraft. Digital tools within healthcare are developing faster than ever before. Therefore, MultiPark researchers gather across groups to develop implementable tools for the diagno
https://www.multipark.lu.se/article/digital-tools-evaluate-symptoms-special-interest-group - 2025-02-11
By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 19 November 2024 Cellular reprogramming can directly convert cells, such as skin cells, into different types of brain cells for studying and treating neurodegenerative disorders. Illustration: Cathrine Ahlenius. Recent discoveries have shown that it is possible to convert one cell type into another, typically by fo
https://www.multipark.lu.se/article/cellular-reprogramming-special-interest-group - 2025-02-11
By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 2 December 2024 Drug development requires a translational approach, from molecular investigations in cell cultures and animal models of neurodegenerative disorders to clinical trials involving patients. Illustration created with Biorender. Breakthroughs of new pharmacological treatments requires translational resea
https://www.multipark.lu.se/article/regenerative-pharmacology-special-interest-group - 2025-02-11
By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 16 October 2024 Emma Nyberg and Lluís Camprubí Ferrer, the Young MultiPark working group members, carry out the interviews. Illustration: Emma Nyberg In the podcast series "Meet our scientists", young MultiPark researchers interview our research group leaders about their academic journey and main scientific focus.
https://www.multipark.lu.se/article/meet-our-scientists-continuation-parkinsons-revolution - 2025-02-11
By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 11 November 2024 Picture: www.vr.se Receiving grants from the Swedish Research Council is viewed as a quality mark and one of the critical steps for young scientists to establish an independent research group. Recently, five of MultiPark’s research leaders were awarded funding for their projects. This year’s suppor
https://www.multipark.lu.se/article/multipark-scientists-granted-support-swedish-research-council - 2025-02-11
By tove [dot] smeds [at] med [dot] lu [dot] se (Tove Smeds) - published 7 November 2024 “Our goal is to make advances in stem cell therapy by modifying and adapting cells to the patient’s needs", explains Malin Parmar. Photo: Tove Smeds Malin Parmar, professor of cellular neuroscience leading one of MultiPark's research groups, along with three researchers in Italy and Denmark, has been awarded th
Published 3 December 2024 Dementia usually means memory problems, but frontotemporal dementia with a loss of ability to empathize with other people can resemble other conditions with empathy problems in psychiatry, such as psychopathy. Photo:Mostphotos Patients with frontotemporal dementia often lack the ability to empathize. A study at Lund University and Karolinska Institutet has now shown that
https://www.multipark.lu.se/article/new-study-shows-how-dementia-affects-brains-ability-empathise - 2025-02-11
By alexis_bento [dot] luis [at] med [dot] lu [dot] se (Alexis Luis Bento) - published 6 December 2024 "This collaboration is truly valuable and with high potential because it merges clinical, molecular, and computational expertise,” states Johan Jakobsson. Photo: iStock/Vitalii Gulenok A team of international researchers led by Professor Johan Jakobsson at Lund University has secured a 52 million
https://www.multipark.lu.se/article/52-million-sek-goes-uncovering-genetic-drivers-parkinsons-disease - 2025-02-11
Published 19 December 2024 Lucia concert in S:t Pauli kyrka in Malmö (Photo by Angela Cenci Nilsson) Dear colleagues and collaborators,As we approach the end of 2024, I believe that we can look back with pride on the many things that we have achieved together this year. We would like to thank all of you for your vital contributions to our research environment, encompassing diverse roles and capaci
https://www.multipark.lu.se/article/seasons-greetings-multipark - 2025-02-11
By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 10 January 2025 The round table discussion at MultiPark retreat 2024. Photo: Megg Garcia-Ryde. Dear colleagues and collaborators,Welcome to a new year with MultiPark!Our Management group has now resumed its activities at full pace, and we are happy to share some fresh information as follows:(i) The dates for this y
https://www.multipark.lu.se/article/kicking-year-packed-program-ahead - 2025-02-11
By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 6 February 2025 In the podcast "Meet Our Scientists", young MultiPark researchers interview our research group leaders about their academic journey and main scientific focus. Illustration:Emma Nyberg. Don't miss the latest episode of MultiPark's podcast Meet our scientists. MultiPark's newest research group leader,
By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 21 January 2025 Contributing to a real research project in one of MultiPark's research groups is an essential part of the Advanced Neuroscience course. Photo: Angela Cenci Nilsson. This week marked the kickoff of MultiPark's Advanced Neuroscience Course. In this exclusive program, students from around the world uni
https://www.multipark.lu.se/article/advanced-neuroscience-course-future-neuroscientists - 2025-02-11
Published 3 April 2019 How do you stop Alzheimer’s disease without a simple way to diagnose it? It’s a real chicken and egg problem, as I wrote last year on TGN. Discovering a treatment for Alzheimer’s requires lots of clinical trials for new drugs—but it’s difficult to enroll participants without a way to identify people who have the disease early enough for potential treatments to work. Read the
https://www.multipark.lu.se/article/unexpected-way-we-might-one-day-diagnose-alzheimers - 2025-02-11
Published 23 April 2019 A new study confirms that a simple blood test can reveal whether there is accelerating nerve cell damage in the brain. The researchers analysed neurofilament light protein (NFL) in blood samples from patients with Alzheimer’s disease. Recently published in JAMA Neurology, the study suggests that the NFL concentration in the blood could be able to indicate if a drug actually
https://www.multipark.lu.se/article/more-evidence-blood-tests-can-detect-risk-alzheimers - 2025-02-11
Published 21 May 2019 In recent years, it has become increasingly clear to researchers that the protein galectin-3 is involved in inflammatory diseases in the brain. A study led by researchers at Lund University in Sweden now shows the de facto key role played by the protein in Alzheimer’s disease. When the researchers shut off the gene that produces this protein in mice, the amount of Alzheimer’s
https://www.multipark.lu.se/article/researchers-block-protein-plays-key-role-alzheimers-disease - 2025-02-11
Published 27 May 2019 Daniella was awarded the prize for "successful effort as a young researcher and group leader". Link to Jeanssons Foundation website (in Swedish)
https://www.multipark.lu.se/article/daniella-ottosson-receives-prize-jeanssons-foundation - 2025-02-11
Published 10 June 2019 The Future Faculty is proud to present the 2019 Minerva Award to Tomas Deierborg, associate professor at the Department of Experimental Medical Sciences.The Minerva award selection committee's motivation for the choice is: "The core values of the Minerva award are honesty, trust, fairness, respect, responsibility and courage. From the nominations it is obvious that Tomas Dei
https://www.multipark.lu.se/article/minerva-award-tomas-deierborg - 2025-02-11
Published 25 June 2019 In today’s JAMA Neurology, researchers led by Oskar Hansson, Lund University, Sweden, report how a fully automated immunoassay for plasma Aβ performed when they put it through its paces. Roche Diagnostic’s Elecsys system predicted Aβ-positive individuals with about 80 percent accuracy. That number improved by 5 percent when the researchers took ApoE genotype into considerati
https://www.multipark.lu.se/article/drawing-closer-alzheimers-blood-test-primary-care - 2025-02-11
Published 6 August 2019 Scientists are becoming more nuanced in how they use amyloid scans—not just to detect the presence of Alzheimer’s pathology, but also to pinpoint disease stage. At this year’s Alzheimer’s Association International Conference, held July 13–18 in Los Angeles, researchers led by Niklas Mattsson and Oskar Hansson at Lund University, Sweden, debuted a new staging scheme. Read th
https://www.multipark.lu.se/article/new-pet-staging-scheme-amyloid - 2025-02-11
